Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-042380

President and CEO sold 15,591 shares at $4.49 ($70,004)

From the SEC's structured data for this filing

Trades in this filing

Touchon Pascal · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Sale : show line 1 in the form −15,591 $4.49 $70,004 441,696 D
Open-market sales · 15,591 sh · avg $4.49 · $70,004
Loading xslF345X03/form4.xml…